• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The development of the new therapeutic drug by targeting host proteases: A novel regulatory method for highly pathogenic infectious diseases.

Research Project

Project/Area Number 18K08453
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54030:Infectious disease medicine-related
Research InstitutionSagami Women's University

Principal Investigator

Okumura Yuushi  相模女子大学, 栄養科学部, 教授 (70294725)

Co-Investigator(Kenkyū-buntansha) 嶋田 昌子  相模女子大学, 栄養科学部, 教授 (30637369)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords高病原性鳥インフルエンザウイルス / ウイルス活性化酵素 / 膜結合型プロテアーゼ / プロテアーゼ阻害剤 / 高病原性感染症 / 膜結合型酵素 / 酵素特異的阻害剤 / 治療薬
Outline of Final Research Achievements

Infection of certain influenza viruses is triggered when its HA is cleaved by host cell proteases. We identified that ubiquitous type II transmembrane serine proteases, MSPL, were candidates of HA-processing proteases for highly pathogenic avian influenza (HPAI) viruses. In addition, we succeeded to solve the crystal structure of MSPL. In this study, based on the structure of MSPL, we first generated specific inhibitors for MSPL. To confirm the involvement of these proteases in HPAI virus infection, highly virulent virus (A/Crow/Kyoto/53/2004 (H5N1)) was infected into MSPL stably expressed cells with or without their specific inhibitors. As a result, we concluded that these proteases specific inhibitors might be suppress HPAI virus multicycle replication and spreading. Furthermore, based on the structure of MSPL, we also constructed a homology model of TMPRSS2. The model may provide the structural insight for the drug development for COVID-19.

Academic Significance and Societal Importance of the Research Achievements

高病原性ウイルスの感染メカニズムにおいて、感染時における宿主側のウイルス活性化酵素を同定できたこと、およびその酵素の立体構造を決定し、酵素特異的阻害剤を開発できたことは、ウイルスが、宿主側のどのような因子を利用して感染・増殖するのかを明らかにしたことを意味し、学術的意義は大きい。同時に、酵素特異的阻害剤が高病原性ウイルス感染症を制御し得ることを証明した事実は、高病原性ウイルス感染症に対する新たな制御法(予防・治療法)の獲得につながり、社会的意義は計り知れない。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (5 results)

All 2021 2018 Other

All Journal Article (2 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 2 results,  Open Access: 2 results) Presentation (1 results) Remarks (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza2021

    • Author(s)
      Ohno Ayako、Maita Nobuo、Tabata Takanori、Nagano Hikaru、Arita Kyohei、Ariyoshi Mariko、Uchida Takayuki、Nakao Reiko、Ulla Anayt、Sugiura Kosuke、Kishimoto Koji、Teshima-Kondo Shigetada、Okumura Yuushi、Nikawa Takeshi
    • Journal Title

      Life Science Alliance

      Volume: 4 Issue: 6 Pages: e202000849-e202000849

    • DOI

      10.26508/lsa.202000849

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Reactive oxygen species up-regulate expression of muscle atrophy-associated ubiquitin ligase Cbl-b in rat L6 skeletal muscle cells.2018

    • Author(s)
      Yuushi Okumura et al.
    • Journal Title

      Am J Physiol Cell Physiol.

      Volume: 印刷中 Issue: 6 Pages: C721-C731

    • DOI

      10.1152/ajpcell.00184.2017

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] 高病原性インフルエンザ感染に関わる宿主酵素MSPLと阻害剤との複合体構造2018

    • Author(s)
      奥村 裕司 他
    • Organizer
      日本病態プロテアーゼ学会
    • Related Report
      2018 Research-status Report
  • [Remarks] 出願公開特許: MSPL特異的阻害剤、及び高病原性インフルエンザウイルス感染又は増殖抑制用組成物

    • URL

      https://www.sagami-wu.ac.jp/labo/licence/

    • Related Report
      2020 Annual Research Report
  • [Patent(Industrial Property Rights)] 高病原性インフルエンザウイルス感染に関わる宿主酵素MSPL特異的な阻害ペプチドの開発2018

    • Inventor(s)
      奥村 裕司 他
    • Industrial Property Rights Holder
      奥村 裕司 他
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-126822
    • Filing Date
      2018
    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi